You have 9 free searches left this month | for more free features.

Cilastatin

Showing 1 - 25 of 55

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hospital Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia Trial (Combination of Imipenem/Cilastatin and

Not yet recruiting
  • Hospital Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia
  • (no location specified)
Feb 2, 2022

Bacterial Infections Trial in Miami, Orlando (XNW4107, Imipenem/Cilastatin)

Active, not recruiting
  • Bacterial Infections
  • XNW4107, Imipenem/Cilastatin
  • Miami, Florida
  • +1 more
Jan 5, 2022

Bacterial Infections Trial in Phoenix (XNW4107, Imipenem/Cilastatin)

Completed
  • Bacterial Infections
  • XNW4107, Imipenem/Cilastatin
  • Phoenix, Arizona
    Pulmonary Associates PA
Jan 5, 2022

Complicated Urinary Tract Infection Including Acute Pyelonephritis Trial (Combination of Imipenem/Cilastatin and XNW4107,

Not yet recruiting
  • Complicated Urinary Tract Infection Including Acute Pyelonephritis
  • Combination of Imipenem/Cilastatin and XNW4107
  • Meropenem
  • (no location specified)
Feb 2, 2022

Cystic Fibrosis, Pneumonia, Bacterial Trial in United States (Imipenem/Cilastatin/Relebactam)

Not yet recruiting
  • Cystic Fibrosis
  • Pneumonia, Bacterial
  • Hartford, Connecticut
  • +6 more
Sep 29, 2022

Carbapenem-Resistant Enterobacteriaceae Infection, KPC, Gram-Negative Bacterial Infections Trial in Charlotte

Recruiting
  • Carbapenem-Resistant Enterobacteriaceae Infection
  • +3 more
  • Charlotte, North Carolina
    Carolinas Medical Center
Jun 16, 2022

Bacterial Infections Trial in Baltimore (XNW4107)

Completed
  • Bacterial Infections
  • Baltimore, Maryland
    Pharmaron CPC
Jan 4, 2022

Bacterial Infections Trial in Orlando (XNW4107, Imipenem/Cilastatin, )

Active, not recruiting
  • Bacterial Infections
  • Orlando, Florida
    Orlando Clinical Research Center (OCRC)
Jan 5, 2022

Obesity, Critical Illness Trial in Chicago (Imipenem/Cilastatin/Relebactam 1.25g)

Enrolling by invitation
  • Obesity
  • Critical Illness
  • Imipenem/Cilastatin/Relebactam 1.25g
  • Chicago, Illinois
    University of Illinois at Chicago
May 18, 2022

Bacterial Pneumonia Trial (Imipenem, Relebactam, Cilastatin)

Completed
  • Bacterial Pneumonia
  • (no location specified)
Apr 3, 2020

Urinary Tract Infections Trial (Cefiderocol, Imipenem/cilastatin)

Completed
  • Urinary Tract Infections
  • (no location specified)
Nov 20, 2019

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Houston (Cefepime, Imipenem/cilastatin-relebactam,

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Malignant Solid Neoplasm
  • Houston, Texas
    M D Anderson Cancer Center
Jul 21, 2022

Intra-abdominal Infections Trial (Relebactam 250 mg, Relebactam 125 mg, Imipenem/cilastatin)

Completed
  • Intra-abdominal Infections
  • Relebactam 250 mg
  • +3 more
  • (no location specified)
Jun 7, 2019

PK/PD and Clinial Outcomes of Beta-lactams in ICU Patients

Unknown status
  • Critical Illness
  • Bacterial Infections
  • Hat Yai, Songkla, Thailand
    Faculty of Medicine, Prince of Songkla University, Thailand
Apr 28, 2020

Febrile Neutropenia, Hematological Malignancy Trial in Amsterdam, The Hague (Discontinuation of imipenem-cilastatin or

Completed
  • Febrile Neutropenia
  • Hematological Malignancy
  • Discontinuation of imipenem-cilastatin or meropenem
  • Amsterdam, Netherlands
  • +1 more
Sep 23, 2019

Dose Finding Study Trial in Madrid (Cilastatin, Placebo)

Completed
  • Dose Finding Study
  • Cilastatin
  • Placebo
  • Madrid, Spain
    Clinical Trials Unit, School of Medicine, Universidad Autónoma d
Oct 5, 2018

Complicated Urinary Tract Infection, Acute Pyelonephritis Trial in Sofia (Sulbactam-ETX2514, Placebo, Imipenem-cilastatin)

Completed
  • Complicated Urinary Tract Infection
  • Acute Pyelonephritis
  • Sofia, Bulgaria
  • +3 more
Jan 20, 2020

Osteomyelitis Trial in Louisville (oral antibiotics, intravenous antibiotics)

Terminated
  • Osteomyelitis
  • oral antibiotics
  • intravenous antibiotics
  • Louisville, Kentucky
    University of Louisville
Apr 2, 2021

Suspected or Documented Gram-negative Bacterial Infection Trial in Worldwide (IMI/REL FDC)

Completed
  • Suspected or Documented Gram-negative Bacterial Infection
  • IMI/REL FDC
  • Little Rock, Arkansas
  • +32 more
Oct 28, 2021

Suspected or Documented Gram-negative Bacterial Infection Trial in Worldwide (IMI/REL, Active Control)

Recruiting
  • Suspected or Documented Gram-negative Bacterial Infection
  • Tucson, Arizona
  • +64 more
Aug 18, 2022

Elimination of Antibiotics During Citrate-anticoagulated

Unknown status
  • Acute Kidney Injury
  • Bacterial Infection
    • Duesseldorf, Germany
      Prof. Kindgen-Milles
    May 7, 2020

    Acinetobacter Baumannii-calcoaceticus Complex, Hospital-acquired Bacterial Pneumonia, Ventilator-associated Bacterial Pneumonia

    Completed
    • Acinetobacter Baumannii-calcoaceticus Complex
    • +4 more
    • ETX2514/Sulbactam + Imipenem/Cilastin
    • Colistin + Imipenem/Cilastin
    • Chicago, Illinois
    • +91 more
    Aug 13, 2021

    Septicemia, Bacterial Infections Trial in Cairo (Tienam 500, Infusion)

    Enrolling by invitation
    • Septicemia
    • Bacterial Infections
    • Tienam 500
    • Infusion
    • Cairo, Egypt
      Ain Shams Univesity Hospital
    Feb 18, 2021